The global biological seed treatment market is estimated to be valued at USD 0.9 billion in 2020 and is projected to reach USD 1.7 billion by 2025, recording a CAGR of 11.9%.The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products. The agricultural and environmental benefits associated with these biological seed treatment solutions are the major factors contributing to the growth of this market globally. Beneficial microorganisms and plant extracts are projected to act as important tools that could help reduce the usage of synthetic fertilizers and chemical pesticides, thereby reducing the investments by farmers and environmental risks.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288
COVID-19 impact on Seed Treatment market
The biological seed treatment market includes major Tier I and II suppliers like BASF SE (Germany), Bayer AG (Germany), Novozymes A/S (Denmark), Syngenta Group (Switzerland) and Corteva Agriscience (US). These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. As a result of the COVID-19 pandemic, there had been a supply chain disruption, due to which the agricultural sector had to face problems, such as labor unavailability, transportation barriers, restriction for market access, and the lack of inventories in some regions. Many manufacturers were facing issues due to the lack of raw material availability, which led to the reduction of seed treatment product manufacturing that includes biological seed treatment products. Post COVID-19, the agricultural activities have normalized, which has helped the companies to deliver products to the required places. Similar to the other biological agricultural product, seed treatment product also plays an important role, as it has been able to serve as an important solution for farmers across the globe.
Driver: Environmental concerns associated with chemical seed treatment
The demand for biological seed treatment has significantly increased as a result of high awareness of their potential and the growing attention to the environmental and health risks associated with conventional chemicals. Chemical seed treatments are detrimental to the environment and pose a serious risk to pollinators. The neonicotinoid class of insecticides is considered highly toxic to honeybees. Microorganisms employed as active substances in pest management are recognized as generally safe for the environment and non-target species, in comparison with synthetic chemicals.
Restraints: Government regulatory barriers
The regulatory environment for active biological ingredients differs between countries and regions. Generally, authorities around the world recognize that biological seed treatment products are beneficial but different from chemical plant protection products. Moreover, this recognition has not necessarily led to consistent approaches in regulatory requirements or review processes. In some countries, biologicals are registered under specific legislation or they may be registered in a similar manner as chemical plant protection products. At times, there are reduced data requirements, and other times there may be no well-defined process at all for their registration.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162422288
By function, seed proyection segment is projected to be the fastest-growing segment in the seed treatment market during the forecast period.
On the basis of function, the biological seed treatment market has broadly been segmented into seed enhancement and seed protection. Biological seed treatments aimed at seed protection provide targeted control of certain pests and fungal diseases during the early seedling stage. Biological seed treatments are used on multiple crops to control a variety of pests. It ensures uniform stand establishment through defense against numerous soil-borne pathogens and insects.
The increasing demand for various crops in the North America region is driving the growth of the biological seed treatment market.
The increasing agricultural practices and requirement of high-quality agricultural produce are factors that are projected to drive the biological seed treatment market growth in this region. The government policies adopted by developed countries for the ban on key active ingredients are the major factors encouraging the growth of this market in North America region. Hence, North America is projected to be the fastest-growing region in the global biological seed treatment market. R&D investments for the development of biological seed treatment and installation of new production capacities by key players are projected to drive the market growth in the next five years.
Key Market Players:
Key players in this market include BASF SE (Germany), Bayer AG (Germany), Novozymes A/S (Denmark), Syngenta Group (Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), and Italpollina (Italy), These major players in this market are focusing on increasing their presence through expansions & investments, mergers & acquisitions, partnerships, joint ventures, and agreements. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities, along with strong distribution networks across these regions.
